Introduction
Mortality following hip fracture is very high. A meta-analysis, based on studies from 1957 to 2009 showed that the all-cause mortality in the first 3 months after hip fracture incidence was 6fold in women and 8-fold in men compared with the general population [1] . Overall mortality within one year following hip fracture is more than 30%, but highly dependent on the comorbidity level before hip fracture [2] .
A systematic review from 2010 showed that surgery delay was associated with mortality up to one year after surgery [3] . The optimal timing of surgery is a long-standing controversy and a frequent clinical concern in the acute management of patients with hip fracture [4] . Proponents of early treatment argue that this approach minimizes the length of time a patient is confined to bed rest, thereby reducing the risk for associated complications, such as pressure sores, deep vein thrombosis, and urinary tract infections. Those favoring delaying surgery beyond the guideline recommendations believe that this approach is required to medically optimize patients, and therefore decrease the risk for perioperative complications [5] . The lack of a broadly accepted threshold for surgery delay illustrates that the controversy remains. Previous studies have used different thresholds for surgery delay, i.e., 12 [6, 7] , 24 [6, 8] and 48 h [6] without clear guideline for clinical indication. Furthermore, there is a paucity of available data on the impact of comorbidity on the association between surgical delay and subsequent mortality [7] . Only five out of the 16 studies included in the systematic review presented adjusted estimates of mortality [3] , most commonly adjusted for American Anesthetists Society score (a measure of a patient's fitness for surgery), age and sex. The role of comorbidity prior surgery, measured with the presence of different medical conditions, on the association between surgery delay and mortality has so far not been examined in details, although it is likely to be important [2] . It may be hypothesized that time delays are less critical in hip fracture patients with comorbidities as the delay can be used to ensure preoperative optimization. In contrast, time delays may be more critical among hip fracture patients without known comorbidity prior admission, who may less likely to be offered preoperative optimization as they are considered to be "healthy" patients. Hence, we aimed to determine whether the association between surgery delay and mortality differ between hip fracture patients with and without known comorbidities. If increasing surgery delay is associated with increasing mortality both in patients with and without comorbidity, this would be an argument for further strengthening the efforts to minimize surgery delay in all patients.
Thus, the aim of this study was to examine the association between surgery delay and mortality in hip fracture patients with and without comorbidities at the time of surgery.
Methods

Study design and setting
This study was a nationwide cohort study using prospective collected data from Danish administrative and medical registers. The Danish National Health Service provides tax-supported health care for the entire Danish population [9] .
Data sources
Patients were identified in the Danish Multidisciplinary Hip Fracture Database (DMHFD) which is a nationwide populationbased clinical quality database established in 2003. The database includes patients older than 65 years of age with a primary diagnosis of hip fracture and a hip fracture operation in the same hospitalization [10] . The DMHFD contains detailed clinical data related to hip fracture treatment and quality of in-hospital care indicators.
We used data from the Danish National Patient Registry (DNPR), which is a population-based administrative registry. This database holds data from all Danish hospitals since 1977 with complete nationwide coverage since 1978. Information reported to DNPR includes administrative data, diagnoses, treatments and examinations related to hospitalizations, outpatient and emergency room visits and data are updated continuously. Until 1993 diagnoses were classified according to the International Classification of Diseases, Revision 8 (ICD-8) and the ICD-10 thereafter [9] .
Further, The Danish Civil Registration System (CRS) was used. CRS is also an administrative register in Denmark established on April 2, 1968, and contains individual-level information on all persons residing in Denmark and daily updated information on migration and vital status [11] .
Finally, data from The Danish National Database of Reimbursed Prescriptions (DNDRP) was used. DNDRP contains the reimbursement records of all reimbursed drugs sold in community pharmacies and hospital-based outpatient pharmacies in Denmark since 2004 and covers the entire Danish population including residents of long-term care institutions. DNDRP contains variables such as pharmaceutical form, trade name, Anatomical Therapeutic Chemical (ATC) Classification System code, and Defined Daily Dose (DDD) of the medicinal product [12] .
Data from the different data sources were linked together using the Civil Personal Registration (CPR) number, which is a unique 10digit personal identification number. This number is the key component of register linkage in Denmark, as it is used in all Danish administrative and medical registers [11] .
Study population
We identified all patients with a first time hip fracture diagnose operated between January 1, 2010 and December 31, 2015 (n = 37,532). Patients with surgery delay of more than 72 h were excluded as there was most likely an error in the registration of either the time of admission or surgery. A total of 36,552 patients were included in the final study population.
Surgery delay
Surgery delay was defined as the time (in hours) from hospital admission to surgery. We defined five dichotomous variables: i) delay more than 3 h ii) delay more than 6 h iii) delay more than 12 h iv) delay more than 24 h and v) delay more than 48 h.
Mortality
As outcome, 0-30-days and 31-90-days all-cause mortality was investigated. 0-30-days all-cause mortality was defined as death within 30 days after surgery and 31-90-days all-cause mortality as death within 90 days after surgery among patients who were alive at day 31 after surgery. As supplementary analysis, 91-180-days and 181-365-days all-cause mortality was also assessed.
Covariates
From the DMHFD following variables were included: sex, age (65-74, 75-84, 85+ years), body mass index (BMI) (underweight: 0-18.5, normal: 18.5-25, overweight: 25+ kg/m 2 when categorized according to the World Health Organisation [13] ), type of fracture (fracture of femoral neck, per-/sub-trochanter fractures), type of surgery (osteosynthesis, total/hemi hip arthroplasty), housing condition (care center, own home) and marital status (not married, married). In addition, comorbidity history was included measured by Charlson Comorbidity Index (CCI) (none: 0 point, medium: 1-2 points, high: >2 points) from the DNPR. Charlson Comorbidity Index is an approach to classify patients with comorbid diseases according to their risk of death from those diseases at the time of enrollment into the study. The index contains 19 disease categories each assigned score 1-6 according to strength of association with one year mortality. It is a weighted index that takes into account the number and for many diseases also the seriousness of the comorbid diseases [14] . Furthermore, information about use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids (non-users and users) were included from the DNDRP. Users of drugs were defined as patients with at least one date of redemption 365 days before surgery and non-users of drugs were patients with no prescription within 365 days before hip fracture surgery.
All codes used in the study is provided in the electronic Supplementary material, Table 1 .
Statistics
We tabulated characteristics of the study population by calculating proportions. Bivariate analysis of the explanatory variables against the outcome was performed to identify the variables to be used in the multivariable model. To evaluate the association between surgery delay and mortality, crude and adjusted Hazard Ratios (HRs) were calculated using Cox proportional hazards regression models. The HRs were adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, marital status, CCI, use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids, and calculated overall and stratified on CCI. Further, we stratified on specific diseases included in the CCI. The assumption of proportional hazards in the dataset were controlled visually by plotting log (cum hazard) as a function of follow up time and found to be appropriate [15] . All statistical analyses was performed with using of SAS 9.4 statistical software (SAS Institute Inc., Cary, USA).
Ethical approval
Study was approved by the Danish Data Protection Agency (journal number 1-16-02-467-15).
Results
Population characteristics
The distribution of surgery delay among the patients is shown in Fig. 1 . A total of 7588 (20.76%) patients had a delay of maximum 12 h, 23,941 (65.50%) had a delay of maximum 24 h and 34,438 (94.22%) had a delay of maximum 48 h. Fig. 1 shows that the majority of patients had a delay between 18-24 hours. Fig. 2 shows the proportion of deaths within 0-30-days and within 31-90-days. We observed some variation in mortality in relation to surgery delay, without any clear association.
Patient characteristics according to surgery delay are shown in Table 1 . Comparing characteristics of the patients with surgery delay 24 versus >24 h, we saw that the distribution of gender, age, BMI, housing condition and marital status was similar in these two groups. Compared to patients with surgery delay 24 h, patients with surgery delay >24 h were slightly more comorbid, had more fractures of femoral neck, total and hemi arthroplasty procedures, and more patients had received anticoagulation drugs. Similar findings regarding fracture type and surgery type were observed for patients with surgery delay >12 versus 12 h and those with surgery delay >48 versus 48 h.
Descriptive statistics on patients with surgery delay more than 3 h vs less than 3 h and more than 6 h vs less than 6 h are shown in the electronic Supplementary material, Table 2 .
0-30-days mortality
The absolute mortality risk and corresponding adjusted HRs with 95% CIs are presented in Fig. 3 . Overall absolute mortality risks were between 10.3% and 12.0% depending on the surgery delay. The adjusted HR for 0-30-days mortality varied from 0.87 (95% CI: 0.72 ; 1.06) for patients with surgery delay over 3 h compared with patients with delay less than 3 h to 1.07 (95% CI: 1.00 ; 1.14) for patients having more than 24 h surgery delay compared with patients with surgery delay 24 h. Thus, we observed no clear threshold for surgery delay indicating increased mortality when looking into entire study population. Fig. 3 . 0-30-days mortality. * Adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, marital status, CCI, use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids.
The analysis stratified by comorbidity showed that the absolute mortality risks increased with increasing comorbidity level irrespective of surgery delay. Our stratified analyses suggest no association between surgery delay and mortality among hip fracture patients with high comorbidity. However, patients with a medium level of comorbidity having more than 24 h surgery delay had increased 0-30-days mortality compared with patients having less than 24 h surgery delay (adjusted HR: 1.12 (95% CI: 1.01 ; 1.24)). In addition, our stratified analyses suggest that surgery delay might be associated with an increased mortality in patients with none comorbidity prior surgery, although the confidence intervals were wide.
31-90-days mortality
Overall absolute mortality risks 31-90-days after surgery were between 7.4% and 8.1% depending on the surgery delay (Fig. 4) . In the overall analysis, patients having more than 24 h surgery delay had an increased adjusted HR of death within 31-90-days of 1.19 (95% CI: 1.10 ; 1.29) compared with patients having 24 h surgery delay. Furthermore, patients with a surgery delay of more than 48 h had an adjusted HR for death of 1.35 (95% CI: 1.16 ; 1.56) compared with patients with surgery delay of less than 48 h.
Similar associations for the thresholds of 24 and 48 h were observed among patients with none and medium comorbidity level. Thus, there were increased adjusted HRs when patients had more than 24 or 48 h delay, for patients with none comorbidity prior surgery (adjusted HR: 1.26 (95% CI: 1.08 ; 1.47) and 1.65 (95% CI: 1.26 ; 2.17), respectively) and for patients with medium level of comorbidity (adjusted HR: 1.21 (95% CI: 1.07 ; 1.36) and 1.25 (95% CI: 1.00 ; 1.57) respectively). In addition, there was an association between surgery delay and mortality for patients with high level of comorbidity (adjusted HR: 1.10 (95% CI: 0.95 ; 1.28)) in patients with surgery delay >24 vs. 24 h and 1.21 (95% CI: 0.91 ; 1.59) in patients with surgery delay >48 vs. 48 h), although the confidence intervals were wide.
91-180-days and 181-365-days mortality
In the electronic Supplementary material, Figs. 1 and 2 the analysis investigating 91-180-days and 181-365-days overall and stratified mortality are shown. The results are mainly in consistent with the result for 31-90-days mortality.
Surgery delay and mortality according to specific comorbidities
The association between surgery delay and mortality stratified on various disease groups was examined for the threshold of 24 h (Fig. 5 ). We observed no association between surgery delay and 30days mortality for patients with individual comorbidities prior surgery. Surgery delay >24 vs 24 h was associated with increased 30-days mortality among patients having ulcer disease (adjusted HR: 1.44 (95% CI: 1.12 ; 1.86). When 31-90-days mortality was examined, a significant difference between the two groups was present for CPD and renal disease. Patients with CPD having a surgery delay more than 24 h had an adjusted HR of 1.26 (95% CI 1.04 ; 1.54) for 31-90-days mortality than patients with a surgery Fig. 4 . 31-90-days mortality. * Adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, marital status, CCI, use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids. delay 24 h and patients with renal disease having a surgery delay more than 24 h had an adjusted HR of 1.69 (95% CI 1.23 ; 2.31) for 31-90-days mortality than patients with a surgery delay 24 h.
Discussion
In this nationwide cohort study of 36,552 hip fracture patients we found for the first time an association between surgery delay and 30-days mortality in hip fracture surgery patients with none and medium level of comorbidity, whereas no such association was observed among hip fracture patients with high comorbidity level. In addition, surgery delay is associated with one year increased risk of dying in both patients with and without comorbidity prior surgery.
Strength and limitations
The strengths of this study include the use of prospectively collected data from national public registers and databases characterized by a high data validity [9, 11, 16] , as well as complete follow up of all patients. In addition, we were able to control and stratify for a wide range of covariates that may potentially have an impact on the association between surgery delay and mortality and the recent study period (2010-2015) means that the study findings reflect current clinical practice, including very recent of current surgical and anesthetic techniques, devices and clinical guidelines.
The primary limitation was the risk of residual or unaccounted confounding as is often the case in observational studies. Hence, we lacked data on socioeconomic factors and life-style factors such as alcohol and smoking, which could at least in theory confound the association between surgery delay and mortality. In addition, misclassification of comorbidity may have occurred, e.g. due to lack of data on psychiatric diseases and severity of some diseases such as diabetes and kidney failure. We did not have information on the specific reasons for surgery delay, however, it is probably likely to be medical for many patients with high comorbidity, and due to lack of surgical capacity for the majority of patients with no comorbidity prior to surgery.
Comparison with previous literature and possible explanations of our finding
Until now, several studies have investigated the association between surgery delay and mortality, but no studies, to our knowledge, investigated the association between surgery delay and mortality stratified on comorbidity, which is what distinguish this study from other studies. By this, our study gives a different perspective to the discussion about surgery delay. Further, most studies failed to adjust for factors as comorbidity, BMI and drug use, while we adjust for those in our study. This can be an explanation of why Nyholm et al. shows a significant association at the 12-, 24-and 48 h threshold on 0-30-days mortality [8] and Bretherton et al. reported a significant association of the 12 h surgery delay and 0-30-days mortality, while we in our study find a borderline significant association at the 24 h threshold on the 0-30-days mortality. This suggest, that these variables have a substantial impact when investigating the association between surgery delay and mortality. Previous studies are also using older data, than the data we use in this study, thus they may not include patients treated according to current clinical guidelines. The difference between the results from former studies and this study can also suggest that the preoperative optimization and treatment for hip fracture patients have changed since then.
That patients with none/medium level of comorbidity are more effected of surgery delay than patients with high level of comorbidity may seem as a surprising founding. One explanation for this could be that sicker patients may benefit from a delay in order to optimize their medical condition while there is no theoretical benefit for healthier patients to wait for surgery. Rather, for the healthy patients there is the potential for increased complications and poor outcome [5] .
A common reason for operative delay include the lack of surgical capacity at the operating room and/or surgical personnel [5] . Selection of patients for delay might not be correct. Given that high comorbidity patients are delayed due to medical reasons they will receive medical optimization. Patients without comorbidity might be more often selected to wait for surgery because these are considered to be "healthy" and can wait. A fundamental misunderstanding may lead to the assumption that healthy patients will not be harmed if they are delayed, because they are healthy. Our study suggest, that such understanding is basically not true for hip fracture patients and it shows that there is no harm for sick patients to be meaningfully delayed while healthy patients may be harmed by a delay. In a review of available literature Lewis et al. suggest a similar understanding. They suggest that an early surgery is appropriate in the relatively fit patient (ASA 1 or 2) with a fracture of the hip, probably within 12 h to 48 h. However, patients with an ASA score of 3 or 4 should allow surgery to be delayed to allow the general condition of the patient to be improved and this decision should not be classed as a fault in management [17] . Hip fracture patients are defined as healthy in our study if they did not have hospital contact for any of the 19 diagnoses included in the CCI and recorded in the DNPR. However, these patients are in general considered to be frail, functionally dependent, have a high prevalence of cognitive impairment, and could have underlying conditions such as dehydration, low kidney function, inflammation which does not necessary require hospital contact and is thus difficult to account with data from the DNPR. Further, patients with known comorbidity often receive organized help at home from nurses, which is not the case for the healthy patients. While waiting for help at home to be organized after discharge, they medical condition deteriorate increasing the risk of dying. Hypothetical, an un-constructive use of the delay in the less vulnerable patients, compared to patients with a known high comorbidity burden at the time of surgery, could lead to an association between delay in surgery and mortality in the less vulnerable patients both in short-and long-term period after surgery.
Clinical implications
The study indicates, that clinicians at the hospital have to continuously target treatment to not only patients with high level of comorbidity, but also hip fracture patients without known comorbidity prior surgery.
Conclusion
There was an association between surgery delay and 30-days mortality in hip fracture surgery patients with none and medium level of comorbidity, whereas no such association was observed among hip fracture patients with high comorbidity level. Surgery delay is associated with one year increased risk of dying in both patients with and without comorbidity prior surgery.
